Functional MRI findings, pharmacological treatment in major depression and clinical response
暂无分享,去创建一个
[1] Yang Wang,et al. Reciprocal Effects of Antidepressant Treatment on Activity and Connectivity of the Mood Regulating Circuit: An fMRI Study , 2007 .
[2] P. Cowen,et al. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients , 2012, Psychological Medicine.
[3] Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram , 2012, Journal of psychopharmacology.
[4] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[5] Kerang Zhang,et al. Effects of an antidepressant on neural correlates of emotional processing in patients with major depression , 2012, Neuroscience Letters.
[6] A. Schene,et al. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder , 2014, Psychiatry Research: Neuroimaging.
[7] Michele T. Diaz,et al. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study. , 2007, The Journal of clinical psychiatry.
[8] S. Kennedy,et al. Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation. , 2013, Journal of affective disorders.
[9] Dean T. Jamison,et al. Measuring the Global Burden of Disease and Risk Factors, 1990–2001 , 2006 .
[10] H. Mayberg. Limbic-cortical dysregulation: a proposed model of depression. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[11] N. Kalin,et al. Reduced Right Ventrolateral Prefrontal Cortex Activity While Inhibiting Positive Affect Is Associated with Improvement in Hedonic Capacity After 8 Weeks of Antidepressant Treatment in Major Depressive Disorder , 2011, Biological Psychiatry.
[12] C. Carter,et al. Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[13] John Suckling,et al. Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment , 2007, Biological Psychiatry.
[14] Soyoung Q. Park,et al. Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy , 2012, Journal of psychopharmacology.
[15] S Surguladze,et al. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score , 2009, Journal of psychopharmacology.
[16] D. Perrett,et al. Facial expression megamix: Tests of dimensional and category accounts of emotion recognition , 1997, Cognition.
[17] M. Mintun,et al. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.
[18] J. Hart,et al. Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. , 2012, The American journal of psychiatry.
[19] Maurizio Fava,et al. The STAR*D project results: A comprehensive review of findings , 2007, Current psychiatry reports.
[20] C. Rorden,et al. Stereotaxic display of brain lesions. , 2000, Behavioural neurology.
[21] P. Ekman,et al. Constants across cultures in the face and emotion. , 1971, Journal of personality and social psychology.
[22] D. Hu,et al. Predicting clinical responses in major depression using intrinsic functional connectivity , 2015, Neuroreport.
[23] Eleanor Hogan,et al. Thinking Too Much , 2008 .
[24] Jonathan Smallwood,et al. Thinking too much: self-generated thought as the engine of neuroticism , 2015, Trends in Cognitive Sciences.
[25] Ke Xu,et al. Brain functional changes in facial expression recognition in patients with major depressive disorder before and after antidepressant treatment , 2012, Neural regeneration research.
[26] N. Kalin,et al. Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment. , 2013, The American journal of psychiatry.
[27] J. John Mann,et al. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: A preliminary study , 2013, Psychiatry Research: Neuroimaging.
[28] Xiao-ping Wu,et al. Hypothalamus-Anchored Resting Brain Network Changes before and after Sertraline Treatment in Major Depression , 2014, BioMed research international.
[29] Hillary S. Schaefer,et al. Event-Related Functional Magnetic Resonance Imaging Measures of Neural Activity to Positive Social Stimuli in Pre- and Post-Treatment Depression , 2006, Biological Psychiatry.
[30] John Suckling,et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. , 2007, The American journal of psychiatry.
[31] Yang Wang,et al. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. , 2007, The Journal of neuropsychiatry and clinical neurosciences.
[32] Y. Su,et al. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging , 2013, Psychological Medicine.
[33] E Friedman,et al. Sharing the wealth , 1990 .
[34] Jessica A. Turner,et al. Sharing the wealth: Neuroimaging data repositories , 2016, NeuroImage.
[35] A. Schene,et al. Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. , 2012, The Journal of clinical psychiatry.
[36] P. Toutouzas,et al. A Magnetic Resonance Imaging Study , 2003 .
[37] C. H. Vanderwolf. Brain, Behavior, and Mind: What do we know and What can we Know? , 1998, Neuroscience & Biobehavioral Reviews.
[38] Teresa A. Victor,et al. Changes in the neural correlates of implicit emotional face processing during antidepressant treatment in major depressive disorder. , 2013, The international journal of neuropsychopharmacology.
[39] B. Biswal. Resting-State Functional Connectivity , 2015 .
[40] Karl J. Friston,et al. A Treatment-Resistant Default Mode Subnetwork in Major Depression , 2013, Biological Psychiatry.
[41] Rebecca Elliott,et al. Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment. , 2012, The American journal of psychiatry.
[42] B. Shan,et al. Resting-state brain alteration after a single dose of SSRI administration predicts 8-week remission of patients with major depressive disorder , 2016, Psychological Medicine.
[43] Cheuk Y. Tang,et al. Ketamine Treatment and Global Brain Connectivity in Major Depression , 2017, Neuropsychopharmacology.
[44] Catherine J. Harmer,et al. Serotonin and emotional processing: Does it help explain antidepressant drug action? , 2008, Neuropharmacology.
[45] S. Lehéricy,et al. Self-referential processing and the prefrontal cortex over the course of depression: a pilot study. , 2010, Journal of affective disorders.
[46] M. Wiesmann,et al. Neural correlates of treatment outcome in major depression. , 2011, The international journal of neuropsychopharmacology.
[47] A. Young,et al. Glutamatergic hypofunction in medication-free major depression: Secondary effects of affective diagnosis and relationship to peripheral glutaminase. , 2018, Journal of affective disorders.
[48] Bradley S Peterson,et al. Antidepressants normalize the default mode network in patients with dysthymia. , 2013, JAMA psychiatry.
[49] Heinrich Sauer,et al. Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. , 2010, Journal of psychiatry & neuroscience : JPN.
[50] John Suckling,et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.
[51] N. Mao,et al. Functional and Anatomical Brain Abnormalities and Effects of Antidepressant in Major Depressive Disorder: Combined Application of Voxel-Based Morphometry and Amplitude of Frequency Fluctuation in Resting State , 2015, Journal of computer assisted tomography.
[52] O. Paulson,et al. Neural correlates of improved executive function following erythropoietin treatment in mood disorders , 2016, Psychological Medicine.
[53] S. Rauch,et al. Neurobiology of emotion perception II: implications for major psychiatric disorders , 2003, Biological Psychiatry.
[54] Rebecca Elliott,et al. Affective Cognition and its Disruption in Mood Disorders , 2011, Neuropsychopharmacology.
[55] C. Reynolds,et al. Resting state functional connectivity and treatment response in late-life depression , 2013, Psychiatry Research: Neuroimaging.
[56] O. Abe,et al. Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis , 2016, Molecular Psychiatry.
[57] Arne Öhman,et al. The role of the amygdala in human fear: Automatic detection of threat , 2005, Psychoneuroendocrinology.
[58] A. Young,et al. Diagnostic and therapeutic utility of neuroimaging in depression: an overview , 2014, Neuropsychiatric disease and treatment.
[59] M. Phillips,et al. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder , 2015, Translational Psychiatry.
[60] Deanna M Barch,et al. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. , 2009, Journal of affective disorders.
[61] Martin Wiesmann,et al. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. , 2011, The Journal of clinical psychiatry.
[62] Li Wang,et al. Differential effects of antidepressant treatment on long-range and short-range functional connectivity strength in patients with major depressive disorder , 2017, Scientific Reports.
[63] Maura L Furey,et al. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. , 2010, Archives of general psychiatry.
[64] M. Brammer,et al. Pattern Classification of Sad Facial Processing: Toward the Development of Neurobiological Markers in Depression , 2008, Biological Psychiatry.
[65] M. Furey,et al. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. , 2013, JAMA psychiatry.
[66] B. Harrison,et al. Effects of Duloxetine Treatment on Brain Response to Painful Stimulation in Major Depressive Disorder , 2010, Neuropsychopharmacology.
[67] John Suckling,et al. A Longitudinal Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Depression After Antidepressant Therapy , 2007, Biological Psychiatry.
[68] R. Elliott,et al. Cognitive Mechanisms of Treatment in Depression , 2012, Neuropsychopharmacology.
[69] Kevin Murphy,et al. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms , 2017, Scientific Reports.
[70] O. Paulson,et al. Effects of erythropoietin on memory‐relevant neurocircuitry activity and recall in mood disorders , 2016, Acta psychiatrica Scandinavica.
[71] Christopher J L Murray,et al. Assessing the burden of disease in the United States using disability-adjusted life years. , 2005, American journal of preventive medicine.
[72] Michael J. Anderle,et al. The neural substrates of affective processing in depressed patients treated with venlafaxine. , 2003, The American journal of psychiatry.
[73] L. Pessoa,et al. Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance , 2010, Nature Reviews Neuroscience.
[74] H. Mayberg. Targeted electrode-based modulation of neural circuits for depression. , 2009, The Journal of clinical investigation.
[75] Gang Wang,et al. Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study , 2017, Metabolic Brain Disease.
[76] G. Dawson,et al. Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls , 2017, Molecular Psychiatry.
[77] Peng Liu,et al. Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine , 2015, BMC Psychiatry.
[78] P. Cowen,et al. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression , 2016, Translational psychiatry.
[79] R. Adolphs. Neural systems for recognizing emotion , 2002, Current Opinion in Neurobiology.
[80] L. Williams,et al. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial , 2015, Neuropsychopharmacology.
[81] M. Furey,et al. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine , 2015, The international journal of neuropsychopharmacology.
[82] Yu-Te Wu,et al. Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naïve major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks. , 2012, Journal of affective disorders.
[83] M. Lowe,et al. Antidepressant Effect on Connectivity of the Mood-Regulating Circuit: An fMRI Study , 2005, Neuropsychopharmacology.
[84] L. Williams,et al. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression , 2016, Biological Psychiatry.
[85] Li Wang,et al. The effects of antidepressant treatment on resting‐state functional brain networks in patients with major depressive disorder , 2015, Human brain mapping.
[86] Vincent Giampietro,et al. Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression. , 2010, Journal of affective disorders.
[87] H J Aizenstein,et al. Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters , 2016, Molecular Psychiatry.
[88] R. Ramasubbu,et al. Amygdala responses to quetiapine XR and citalopram treatment in major depression: the role of 5‐HTTLPR‐S/Lg polymorphisms , 2016, Human psychopharmacology.
[89] S. Williams,et al. Instability of default mode network connectivity in major depression: a two-sample confirmation study , 2017, Translational Psychiatry.
[90] S. Lehéricy,et al. Antidepressant short-term and long-term brain effects during self-referential processing in major depression , 2016, Psychiatry Research: Neuroimaging.
[91] M. Wiesmann,et al. Brain activation predicts treatment improvement in patients with major depressive disorder. , 2011, Journal of psychiatric research.
[92] Osamu Abe,et al. Computational meta‐analysis of statistical parametric maps in major depression , 2016, Human brain mapping.
[93] Peter Redgrave,et al. Faculty of 1000 evaluation for Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance. , 2010 .
[94] Klaus P. Ebmeier,et al. Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses , 2012, European Neuropsychopharmacology.
[95] L. Marangell,et al. Effects of antidepressant therapy on neural components of verbal working memory in depression , 2017, Journal of psychopharmacology.